These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20961308)

  • 41. Leptin, adiponectin, resistin, and ghrelin--implications for inflammatory bowel disease.
    Karmiris K; Koutroubakis IE; Kouroumalis EA
    Mol Nutr Food Res; 2008 Aug; 52(8):855-66. PubMed ID: 18383234
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunological basis of inflammatory bowel disease: role of the microcirculation.
    Laroux FS; Grisham MB
    Microcirculation; 2001 Oct; 8(5):283-301. PubMed ID: 11687942
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adventitial lymphatic vessels -- an important role in atherosclerosis.
    Xu X; Lin H; Lv H; Zhang M; Zhang Y
    Med Hypotheses; 2007; 69(6):1238-41. PubMed ID: 17825501
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Iron in the inflammed gut: another pro-inflammatory hit?
    Weiss G
    Gut; 2011 Mar; 60(3):287-8. PubMed ID: 21193440
    [No Abstract]   [Full Text] [Related]  

  • 45. Review article: lymphatic system and associated adipose tissue in the development of inflammatory bowel disease.
    von der Weid PY; Rainey KJ
    Aliment Pharmacol Ther; 2010 Sep; 32(6):697-711. PubMed ID: 20636483
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
    Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
    Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mouse models of inflammatory bowel disease.
    Wirtz S; Neurath MF
    Adv Drug Deliv Rev; 2007 Sep; 59(11):1073-83. PubMed ID: 17825455
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Advances in therapeutic interventions targeting the vascular and lymphatic endothelium in inflammatory bowel disease.
    D'Alessio S; Tacconi C; Fiocchi C; Danese S
    Curr Opin Gastroenterol; 2013 Nov; 29(6):608-13. PubMed ID: 24100721
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impairments in the intrinsic contractility of mesenteric collecting lymphatics in a rat model of metabolic syndrome.
    Zawieja SD; Wang W; Wu X; Nepiyushchikh ZV; Zawieja DC; Muthuchamy M
    Am J Physiol Heart Circ Physiol; 2012 Feb; 302(3):H643-53. PubMed ID: 22159997
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mechanisms of VIP-induced inhibition of the lymphatic vessel pump.
    von der Weid PY; Rehal S; Dyrda P; Lee S; Mathias R; Rahman M; Roizes S; Imtiaz MS
    J Physiol; 2012 Jun; 590(11):2677-91. PubMed ID: 22451438
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inflammation-induced lymphatic architecture and bone turnover changes are ameliorated by irisin treatment in chronic inflammatory bowel disease.
    Narayanan SA; Metzger CE; Bloomfield SA; Zawieja DC
    FASEB J; 2018 Sep; 32(9):4848-4861. PubMed ID: 29596023
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dichotomous effects of in vivo and in vitro ionizing radiation exposure on lymphatic function.
    Singh R; Heaps CL; Muthuchamy M; Deveau MA; Stewart RH; Laine GA; Dongaonkar RM
    Am J Physiol Heart Circ Physiol; 2023 Jan; 324(1):H155-H171. PubMed ID: 36459446
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cellular and molecular mediators of lymphangiogenesis in inflammatory bowel disease.
    Ocansey DKW; Pei B; Xu X; Zhang L; Olovo CV; Mao F
    J Transl Med; 2021 Jun; 19(1):254. PubMed ID: 34112196
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Emerging trends in the pathophysiology of lymphatic contractile function.
    Chakraborty S; Davis MJ; Muthuchamy M
    Semin Cell Dev Biol; 2015 Feb; 38():55-66. PubMed ID: 25617600
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regulatory mechanisms in lymphatic vessel contraction under normal and inflammatory conditions.
    von der Weid PY; Muthuchamy M
    Pathophysiology; 2010 Sep; 17(4):263-76. PubMed ID: 19945830
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pathophysiology of aged lymphatic vessels.
    Shang T; Liang J; Kapron CM; Liu J
    Aging (Albany NY); 2019 Aug; 11(16):6602-6613. PubMed ID: 31461408
    [TBL] [Abstract][Full Text] [Related]  

  • 57. IBD pathogenesis in 2014: Molecular pathways controlling barrier function in IBD.
    Atreya R; Neurath MF
    Nat Rev Gastroenterol Hepatol; 2015 Feb; 12(2):67-8. PubMed ID: 25446731
    [No Abstract]   [Full Text] [Related]  

  • 58. Inflammatory bowel disease and lymphology: a discontinuous thread revisited in the molecular era.
    Witte MH
    Lymphology; 2014 Mar; 47(1):1-2. PubMed ID: 25109165
    [No Abstract]   [Full Text] [Related]  

  • 59. The primary valves in the initial lymphatics during inflammation.
    Lynch PM; Delano FA; Schmid-Schönbein GW
    Lymphat Res Biol; 2007; 5(1):3-10. PubMed ID: 17508898
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Review article: lymphatic vessel pumping and inflammation--the role of spontaneous constrictions and underlying electrical pacemaker potentials.
    von der Weid PY
    Aliment Pharmacol Ther; 2001 Aug; 15(8):1115-29. PubMed ID: 11472314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.